Delivery Order SPE2DR25D1004-SPE2DR26FSWF0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $54,157.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $78,459.61 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,902.96 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on December 5, 2025, with a completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $10,852.23 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by December 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,421.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $16,220.13 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $51,982.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $18,114.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $21,384.94 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price arrangement. The award was made on November 25, 2025, with an ultimate completion date of November 26, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWF0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,000.02 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location and is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The contract vehicle demonstrates AmerisourceBergen's established capability to fulfill federal pharmaceutical procurement requirements through competitive processes and its role within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/7/25 |